First humans test new mystery pill in early safety trial
NCT ID NCT07222709
Summary
This is the very first study testing a new experimental drug called ABBV-1042 in people. Researchers will give increasing single doses of the oral drug to 48 healthy volunteers to check for side effects and see how the body processes it. The main goal is to determine if the drug is safe and well-tolerated before testing it in people with specific medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 279405
RECRUITINGGrayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.